Tag: EBIO

Blue Horseshoe Stocks: BTCS Recap, EVOK & More

BTCS, Inc. BTCS

We caught BTCS on a routine scan yesterday morning after noticing some abnormal activity from the session prior. Our timing ended up being extremely fortuitous, with the stock making quite an impressive morning run.

From a low of .0013, it surged up as high as .0024 just prior to midday, for a healthy pop of 85% on almost ten times the three-month average volume. If BTCS can hold support at or above yesterday’s swing low, we’ll continue to be interested in the possibilities it may provide.

Evoke Pharma, Inc. EVOK

EVOK is another fresh play that we’re taking a look at for the first time this morning. The stock has recently fallen off of a cliff, as we’ve pointed out on the annotated chart below. Beginning with a massive gap-down earlier this month, followed by several sessions of backsliding which culminated in a new 52-week low (1.52) being set on Monday.

Yesterday’s bottom-bounce activity is what has us on alert. The stock is heavily oversold, and could be in line for a substantial rebound. We’ll want to be hanging around when that occurs, because even a return to the bottom of the chart gap at 3.50, from current levels, would spell an opportunity for significant gains.

Tempur Sealy International, Inc. TPX – Options Idea

TPX is fresh off an earnings beat this morning which has it gapping up into the $70-range. We’re going to signal a range of longer-term options ideas for us to track in the days and weeks to come. Our area of interest here is going to be the TPX 08/19 $70-80 Calls, giving us just over three weeks’ time to see a continued PPS recovery. 

Extended Watchlist:
SOULD, GYST, GRPN, EBIO, EPRS, WEYL
 NSRS(Potential Bottom Bouncer)

Blue Horseshoe Stocks: EBIO, HRB Updates & More

H&R Block, Inc. HRB – Options Update

The options idea we formulated and passed along to our readers on Friday for HRB was far away our best play of the week, and an excellent way to wrap it up. Our specific target range that we highlighted in this case was the HRB 06/17 $21-23 Calls. and we ended up seeing monstrous moves out of each of the contained contracts.

$21 Calls – Trading Range: .60-3.30 – Max Gain: 450%
$22 Calls – Trading Range: .15-2.30 – Max Gain: 1430%
$23 Calls– Trading Range: .05-1.30 – Max Gain: 2500%

______

Added Reminder:

The other options play we set our sights on in Friday morning’s report was Global Blood Therapeutics,Inc. GBT – 06/17 $20-30 Calls. We saw some moderate activity as the stock ran early in the day, before tapering off. As they don’t expire until the end of this week, we just wanted to reiterate the possibility of more pronounced moves if GBT maintains support at 22.00 or above.

Eleven Biotherapeutics, Inc. EBIO 

The last time we reminded folks about our interest in EBIO, a stock that has appeared in our reports many times in the past, was on June 3rd. On that day, we were commenting on an earlier alert we put out on it back in May while EBIO’s PPS was at .80, after seeing it run up to its then-high of 2.10.

It ended up topping out at 2.60 on the afternoon of the 3rd, and has since been under light consolidation. It reached a support level of 1.62 on Friday, before beginning to rebound, and this morning it has gapped up hard in the premarket to a new high of 3.55 on the strength of an attractive PR (link below).

From our observed low in May, it represents an overall increase of 344% We’ll want to see the stock’s previous resistance level of 2.60 hold as support on any early pullbacks.

Extended Watchlist:
AROPQ, EXAD, TRQ, GIG, AMRS, QURE,
FLXN(Big Insider Buying)

Blue Horseshoe Stocks: Reviewing IMMU, EBIO & More

Immunomedics, Inc. IMMU

We began tracking IMMU last month, mentioning it for the first time on May 13th, and then again in a followup on the 20th. Our timeliness in bringing what was already a steady climber to the table, as you can plainly see on the chart below.

It’s been a solid few weeks for the stock since that time. It has risen from our observed low of 3.59 to a new high of 5.44 yesterday, marking a solid 52% PPS increase in just a short time. We can also see that the volume has been steadily creeping up as well.

The last time the stock was this overbought, we saw a leveling out but not much of a consolidation. We’ll look for a similar phenomenon to occur from this point forward, and for IMMU to ultimately continue its general uptrend until we see evidence to the contrary.

Eleven Biotherapeutics, Inc. EBIO

Speaking of plays we called last month that have enjoyed extended moves up, we’ve also got on update on EBIO this morning. We tagged this stock for observation in the first week of May, and would catch it trading at a low of .80.

From there it’s been a fairly steady climb, and yesterday it too shot to new highs. As of yesterday’s top mark of 2.10, we’d witnessed a one-month rise of 163% as the stock temporarily cracked through the 200DMA. We’ll look for it to hold support at or above previous resistance in the 1.70 area on any pullbacks.

Fresh Options Idea

For a closing idea on this short week, we’ve taken notice of the chart on iShares Silver Trust SLV. It’s gapping up moderately in the premarket this morning after recently bouncing off of its lowest price in a couple of months.

Accordingly, today we’re going to look to possibly take advantage of the activity in the SLV $15-16 Weekly Calls* for intraday flip opportunities.
___

*Caution: As always, heed our caution with regard to trading options contracts with a weekly expiration on Friday. It’s something only to be attempted by advanced traders!

Extended Watchlist:
GDSI, SNST, SIGA SAND, AUY, USLV